We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-2.4%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.32B
AUM Growth
-$216M
Cap. Flow
-$62.5M
Cap. Flow %
-1.18%
Top 10 Hldgs %
23.94%
Holding
294
New
29
Increased
89
Reduced
98
Closed
32

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$46.6M
2
GILD icon
Gilead Sciences
GILD
+$37M
3
BCR
CR Bard Inc.
BCR
+$31.1M
4
CVS icon
CVS Health
CVS
+$27.8M
5
DHR icon
Danaher
DHR
+$26.6M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$36.5M
2
PNC icon
PNC Financial Services
PNC
+$34.3M
3
CELG
Celgene Corp
CELG
+$32.4M
4
AGN
Allergan plc
AGN
+$28M
5
CNC icon
Centene
CNC
+$27.3M

Sector Composition

Rank Sector Weight
1 Technology 24.2%
2 Healthcare 23.21%
3 Financials 21.91%
4 Communication Services 9.94%
5 Industrials 5.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTW icon
126
Willis Towers Watson
WTW
$28.6B
$11.3M 0.21%
+95,000
New +$10.9M
LOGM
127
DELISTED
LogMein, Inc.
LOGM
$11.2M 0.21%
221,288
+42,092
+23% +$2.17M
AMAT icon
128
Applied Materials
AMAT
$410B
$11M 0.21%
518,594
+114,616
+28% +$2.09M
SYNA icon
129
Synaptics
SYNA
$4.55B
$11M 0.21%
137,627
-166,485
-55% -$12.6M
NTES icon
130
NetEase
NTES
$79.2B
$10.9M 0.2%
378,510
-96,445
-20% -$2.89M
RLI icon
131
RLI Corp
RLI
$5.88B
$10.9M 0.2%
325,000
-5,000
-2% -$157K
SPNT icon
132
SiriusPoint
SPNT
$3.01B
$10.8M 0.2%
950,000
– –
HRTG icon
133
Heritage Insurance Holdings
HRTG
$864M
$10.8M 0.2%
675,000
+75,000
+13% +$1.37M
AFL icon
134
Aflac
AFL
$64.4B
$10.7M 0.2%
340,000
-5,000
-1% -$149K
UBS icon
135
UBS Group
UBS
$172B
$10.7M 0.2%
657,754
+89,322
+16% +$1.45M
RL icon
136
Ralph Lauren
RL
$22.6B
$10.2M 0.19%
105,445
-874
-0.8% -$85.7K
ADBE icon
137
Adobe
ADBE
$94.5B
$9.38M 0.18%
99,977
+22,758
+29% +$1.97M
OSPN icon
138
OneSpan
OSPN
$562M
$9.34M 0.18%
606,693
-116,435
-16% -$1.73M
CELG
139
DELISTED
Celgene Corp
CELG
$9.02M 0.17%
90,149
-314,702
-78% -$32.4M
WFC icon
140
Wells Fargo
WFC
$264B
$9M 0.17%
186,218
+12,420
+7% +$608K
TSRO
141
DELISTED
TESARO, Inc.
TSRO
$8.81M 0.17%
200,000
-245,853
-55% -$9.87M
PGR icon
142
Progressive
PGR
$125B
$8.79M 0.17%
250,000
-51,500
-17% -$1.65M
ALGN icon
143
Align Technology
ALGN
$12B
$8.72M 0.16%
+120,000
New +$7.86M
INGN icon
144
Inogen
INGN
$171M
$8.71M 0.16%
193,524
-106,776
-36% -$3.8M
DVAX
145
DELISTED
Dynavax Technologies
DVAX
$8.27M 0.16%
430,000
-650,944
-60% -$13.2M
ABBV icon
146
AbbVie
ABBV
$454B
$8.05M 0.15%
141,027
-106,539
-43% -$5.94M
ELGX
147
DELISTED
Endologix Inc
ELGX
$7.96M 0.15%
95,271
-90,009
-49% -$7.42M
ULTI
148
DELISTED
Ultimate Software Group Inc
ULTI
$7.84M 0.15%
40,542
+21,239
+110% +$3.7M
ARCC icon
149
Ares Capital
ARCC
$13.6B
$7.78M 0.15%
525,000
+60,000
+13% +$826K
BMY icon
150
Bristol-Myers Squibb
BMY
$128B
$7.66M 0.14%
120,000
-578,070
-83% -$36.5M
4 5
6
7 8

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q1 2016 Portfolio in Review

As of Q1 2016, Polar Capital held 294 positions worth $5.32B, down 3.9% from $5.53B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital's Q1 2016 filing shows 29 new, 89 increased, 98 reduced and 32 closed positions. Its largest new stake was Union Pacific: 603,004 shares worth $48M. The largest sale was Bristol-Myers Squibb, an estimated $36.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Polar Capital's largest Q1 2016 buy was Union Pacific: 603,004 shares worth $48M.
  • Polar Capital added most to Gilead Sciences in Q1 2016, an estimated $37M increase.
  • Polar Capital's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $36.5M.
  • Polar Capital fully exited Centene in Q1 2016, selling an estimated $27.3M.
  • Polar Capital's ten largest holdings make up 24% of its $5.32B portfolio in Q1 2016.
  • Polar Capital opened 29 new positions and closed 32 in Q1 2016.
  • Polar Capital's portfolio value fell 3.9% quarter-over-quarter to $5.32B.

Based on Polar Capital's 13F filing for Q1 2016, filed 16 May 2016.